Milbank LLP advised NORD Holding Unternehmensbeteiligungsgesellschaft mbH ("NORD Holding") and the company's founder Johannes Hagenmeyer on the joint sale of their shareholdings in HG Medical Holding GmbH ("HG Medical") to Astorg MidCap ("Astorg"). HG Medical is a leading global contract manufacturer of complex orthopedic implants.
With a 50-year history and assets under management of €3 billion, NORD Holding Unternehmensbeteiligungsgesellschaft mbH is one of the leading private equity asset management companies in Germany. The business consists of the direct investments and the fund investments divisions.
With NORD Holding, HG Medical has become a fast-growing and even more customer-centric and solution-driven organization with outstanding engineering capabilities and manufacturing excellence. The investment from Astorg will enable the company to further expand its capacity and service offering to meet the growing demand for outsourced manufacturing in the orthopedic sector. HG Medical is Astorg's first investment in Germany.
The Milbank team that advised NORD Holding was led by partner Martin Erhardt (Corporate/M&A) and included partners Thomas Kleinheisterkamp (Tax), Thomas Ingenhoven (Finance), Alexander Rinne (Antitrust) and special counsel Michael Pujol (Corporate/M&A), as well as associates Svenja Tauchmann, Markus Lutterotti (both Corporate/M&A), Lara Milione (Finance) and transaction lawyer Antonia Fichtner (Corporate/M&A).
